Bharat B. Aggarwal
Bharat B. Aggarwal received his Ph.D. degree in biochemistry from the University of California, Berkeley, he did his postdoctoral fellowship in endocrinology from the University of California Medical Center, San Francisco, and then worked in a Biotechnology company (Genentech Inc.), where he discovered TNF-alfa and TNF-beta, essential components of the Immune System. In 1989, Dr. Aggarwal accepted a position as a Professor and Chief of the Cytokine Research Section at the University of Texas M. D. Anderson Cancer in Houston. He currently holds the Ransom Horne Jr. Endowed Professorship in Cancer Research. He has published almost 450 original peer-reviewed articles and invited reviews; currently, serving on the board of numerous journals, edited 12 books, and been granted almost 35 patents. Since 2001, Dr. Aggarwal has been listed as one of the World’s Most Highly Cited Immunologists by the Institute of Scientific Information. In 2005, Dr. Aggarwal received the Ranbaxy Award for his outstanding contributions to science. In 2006, Dr. Aggarwal, for his outstanding contributions to science, received the similar Award from the American Association of Indian Scientists in Cancer Research. Dr. Aggarwal’s current research is identification of novel inhibitors of NF-kB pathway (from traditional sources) which can suppress pro-inflammatory, anti-apoptotic, cell proliferative, invasive, and angiogenic gene products for the prevention and therapy of cancer and other proinflammatory diseases.
Biography Updated on 15 July 2007